Coloplast Statistics
Total Valuation
Coloplast has a market cap or net worth of 22.33 billion. The enterprise value is 25.98 billion.
| Market Cap | 22.33B |
| Enterprise Value | 25.98B |
Important Dates
The next estimated earnings date is Tuesday, August 19, 2025.
| Earnings Date | Aug 19, 2025 |
| Ex-Dividend Date | May 8, 2025 |
Share Statistics
| Current Share Class | 207.17M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +1.60% |
| Shares Change (QoQ) | -0.04% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 142.57M |
Valuation Ratios
The trailing PE ratio is 33.92 and the forward PE ratio is 26.93.
| PE Ratio | 33.92 |
| Forward PE | 26.93 |
| PS Ratio | 5.55 |
| PB Ratio | 9.10 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 30.65 |
| P/OCF Ratio | 24.51 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.21, with an EV/FCF ratio of 35.66.
| EV / Earnings | 39.46 |
| EV / Sales | 6.03 |
| EV / EBITDA | 19.21 |
| EV / EBIT | 22.32 |
| EV / FCF | 35.66 |
Financial Position
The company has a current ratio of 0.95, with a Debt / Equity ratio of 1.43.
| Current Ratio | 0.95 |
| Quick Ratio | 0.57 |
| Debt / Equity | 1.43 |
| Debt / EBITDA | 2.78 |
| Debt / FCF | 4.82 |
| Interest Coverage | 9.07 |
Financial Efficiency
Return on equity (ROE) is 27.42% and return on invested capital (ROIC) is 11.45%.
| Return on Equity (ROE) | 27.42% |
| Return on Assets (ROA) | 9.64% |
| Return on Invested Capital (ROIC) | 11.45% |
| Return on Capital Employed (ROCE) | 19.65% |
| Revenue Per Employee | 240,552 |
| Profits Per Employee | 39,328 |
| Employee Count | 16,639 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 2.45 |
Taxes
In the past 12 months, Coloplast has paid 282.54 million in taxes.
| Income Tax | 282.54M |
| Effective Tax Rate | 30.03% |
Stock Price Statistics
The stock price has decreased by -16.76% in the last 52 weeks. The beta is 0.55, so Coloplast's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | -16.76% |
| 50-Day Moving Average | 99.49 |
| 200-Day Moving Average | 113.59 |
| Relative Strength Index (RSI) | 56.67 |
| Average Volume (20 Days) | 232 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Coloplast had revenue of 4.03 billion and earned 658.38 million in profits. Earnings per share was 2.92.
| Revenue | 4.03B |
| Gross Profit | 2.72B |
| Operating Income | 1.09B |
| Pretax Income | 940.92M |
| Net Income | 658.38M |
| EBITDA | 1.22B |
| EBIT | 1.09B |
| Earnings Per Share (EPS) | 2.92 |
Balance Sheet
The company has 105.63 million in cash and 3.52 billion in debt, giving a net cash position of -3.41 billion.
| Cash & Cash Equivalents | 105.63M |
| Total Debt | 3.52B |
| Net Cash | -3.41B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 2.45B |
| Book Value Per Share | 10.90 |
| Working Capital | -72.45M |
Cash Flow
In the last 12 months, operating cash flow was 910.93 million and capital expenditures -182.27 million, giving a free cash flow of 728.65 million.
| Operating Cash Flow | 910.93M |
| Capital Expenditures | -182.27M |
| Free Cash Flow | 728.65M |
| FCF Per Share | n/a |
Margins
Gross margin is 67.52%, with operating and profit margins of 26.99% and 16.35%.
| Gross Margin | 67.52% |
| Operating Margin | 26.99% |
| Pretax Margin | 23.36% |
| Profit Margin | 16.35% |
| EBITDA Margin | 30.33% |
| EBIT Margin | 26.99% |
| FCF Margin | 18.09% |
Dividends & Yields
This stock pays an annual dividend of 3.17, which amounts to a dividend yield of 3.38%.
| Dividend Per Share | 3.17 |
| Dividend Yield | 3.38% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 109.07% |
| Buyback Yield | -1.60% |
| Shareholder Yield | 1.78% |
| Earnings Yield | 2.95% |
| FCF Yield | 3.26% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Coloplast has an Altman Z-Score of 5.13 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.13 |
| Piotroski F-Score | 6 |